ArticleInternational journal of biological sciences2019

Osimertinib and pterostilbene in EGFR-mutation-positive non-small cell lung cancer (NSCLC).

Jillian Wilhelmina Paulina Bracht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.